- AdventHealth Research Institute
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity. Most of what we know about this comes from animal studies or human observations, so there is still a lot to learn.
Our recent study, published in the American Journal of Clinical Nutrition, aimed to fill in some of these gaps. We looked at small molecules in the body—called metabolites—including those that are produced when food is digested by both our bodies and the microbes in our gut.
We studied healthy adults without obesity and fed them two different diets:
• A high-fiber diet (called the Microbiome Enhancer Diet or MBD), which was low in processed foods.
• A Western-style diet (WD), which was low in fiber and high in processed foods.
Both diets had the same number of calories and macronutrient percentages, and participants were carefully monitored to make sure they ate exactly what was provided.
Our study goals were:
1. To find chemical “fingerprints” of each diet that could be validated in future research.
2. To understand how diet and gut microbes work together to affect how much energy the body absorbs.
What we found:
1. The high-fiber diet changed many of the body’s metabolites compared to the processed diet. These changes could help identify diets that modulate how much energy is absorbed from the diet, in part by altering the gut microbiome.
2. Some of the changes in metabolites excreted in the stool were linked to less energy being absorbed and more growth of gut microbes—suggesting potential mechanisms by which the microbes might be using some of the energy themselves and preventing energy from being absorbed by the host.
3. Surprisingly, the high-fiber diet increased levels of a ketone body called beta-hydroxybutyrate, which usually rises during fasting or low-carb diets. This happened even though both diets had the same number of calories which were calculated to maintain participants’ starting body weight, hinting that an MBD might mimic some effects of fasting.
Why this matters:
These findings help us understand how diet and gut microbes work together to influence energy use in the body. This could lead to new ways to prevent or treat obesity by targeting the gut microbiome.
Recent News
Alcohol, Marijuana and Type 1 Diabetes:
Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...
GLP-1 Medications: The Next Chapter in Diabetes Care
Ozempic®. Wegovy®. Zepbound®. Just a few years ago, most people had never heard these names. Today, they're among the most talked-about medications in the world. While much of the public conversation...
Q&A: Alcohol, Marijuana and Type 1 Diabetes
A Conversation with Daria Igudesman, PhD, RD, Postdoctoral Research Fellow, AdventHealth Translational Research Institute.
The Science That Moves Medicine Forward:
Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Six Breakthroughs Shaping the Future of Diabetes Care
Several members of the AdventHealth Translational Research Institute (TRI) team traveled to New Orleans in June to attend the American Diabetes Association's (ADA) 2026 Scientific Sessions, where more...
AHRI Investigator Receives Prestigious American Diabetes Association Junior Faculty Development Award
The AdventHealth Translational Research Institute (TRI) is proud to announce that Dr. Justine Mucinski has received an American Diabetes Association (ADA) Junior Faculty Development Award.
Dr. Richard Pratley Featured in Nature Medicine for Breakthrough Obesity Research
Dr. Richard E. Pratley, senior investigator at the AdventHealth Translational Research Institute, has been featured as the corresponding author of a newly published study in Nature Medicine, one of...
Dr. Sparks Participates in LIMNA’s 17th Annual Metabolism and Aging Symposium
AdventHealth researcher Dr. Lauren Sparks recently had the honor of participating in LIMNA’s 17th Annual Symposium on “Metabolism and Aging” at the Olympic Museum in Lausanne
Advancing Cancer Research Closer to Home
At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...
AdventHealth Research Institute Researchers to Present at American Diabetes Association Scientific Sessions
AdventHealth Research Institute (AHRI) is proud to have a strong presence at the American Diabetes Association (ADA) 2026 Scientific Sessions, with multiple investigators and research team members...
Moving More, Managing Better
For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.